LOAMU
SLN
Lombard Odier Asset Management (USA)’s Silence Therapeutics SLN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.81M | Hold |
1,849,734
| – | – | 0.59% | 7 |
|
|
2025
Q1 | $4.04M | Sell |
1,849,734
-6,289
| -0.3% | -$13.7K | 0.32% | 13 |
|
|
2024
Q4 | $10.2M | Sell |
1,856,023
-808,054
| -30% | -$4.44M | 0.75% | 4 |
|
|
2024
Q3 | $36.2M | Buy |
2,664,077
+258,079
| +11% | +$3.51M | 2.41% | 1 |
|
|
2024
Q2 | $36.8M | Buy |
2,405,998
+17,086
| +0.7% | +$261K | 2.72% | 1 |
|
|
2024
Q1 | $41.6M | Sell |
2,388,912
-1,490,261
| -38% | -$25.9M | 1.01% | 3 |
|
|
2023
Q4 | $54.5M | Sell |
3,879,173
-178,759
| -4% | -$2.51M | 0.99% | 2 |
|
|
2023
Q3 | $33.7M | Sell |
4,057,932
-62,484
| -2% | -$520K | 0.76% | 4 |
|
|
2023
Q2 | $18.7M | Buy |
4,120,416
+161,315
| +4% | +$731K | 0.4% | 5 |
|
|
2023
Q1 | $20.7M | Buy |
3,959,101
+83,367
| +2% | +$436K | 0.46% | 4 |
|
|
2022
Q4 | $50.6M | Sell |
3,875,734
-20,861
| -0.5% | -$272K | 1.29% | 2 |
|
|
2022
Q3 | $35.7M | Buy |
3,896,595
+130,226
| +3% | +$1.19M | 1.04% | 2 |
|
|
2022
Q2 | $38.2M | Buy |
3,766,369
+134,135
| +4% | +$1.36M | 1.47% | 1 |
|
|
2022
Q1 | $55.7M | Buy |
3,632,234
+159,713
| +5% | +$2.45M | 2.04% | 1 |
|
|
2021
Q4 | $83M | Buy |
3,472,521
+2,874,380
| +481% | +$68.7M | 3.24% | 1 |
|
|
2021
Q3 | $10.7M | Sell |
598,141
-314,993
| -34% | -$5.61M | 0.47% | 9 |
|
|
2021
Q2 | $21.6M | Sell |
913,134
-285,007
| -24% | -$6.74M | 0.86% | 4 |
|
|
2021
Q1 | $24.4M | Buy |
1,198,141
+658,141
| +122% | +$13.4M | 0.9% | 6 |
|
|
2020
Q4 | $10.2M | Hold |
540,000
| – | – | 0.49% | 16 |
|
|
2020
Q3 | $8.1M | Buy |
+540,000
| New | +$8.1M | 0.53% | 19 |
|